Paula Miliani de Marval received her PhD in tumor biology at the University of Texas, M.D. Anderson Cancer Center. Her research focused on the role of cyclin dependent kinase-4 in normal and neoplastic skin proliferation. After graduation she pursued additional postdoctoral training in in vivo models for cancer research at the Lineberger Comprehensive Cancer Center, UNC-Chapel Hill, and Duke University in Durham, North Carolina. She joined Charles River in 2014 and works with clients to guide them in the study design, interpretation and evaluation of preclinical oncology studies and associated therapeutic targets. Dr. Miliani de Marval also leads the humanized mouse model project initiative.